NSW Health Annual Report 2013-14
The Cancer Institute NSW officially became a pillar of NSW Health in 2013. As such, the Institute’s key achievements for the 2013–14 financial year have been highlighted in the NSW Health Annual Report 2013–14.
Key achievements for the Cancer Institute NSW 2013–14, as outlined in the NSW Health Annual Report:
- Implemented seven anti-tobacco media campaigns in 2013–14. Ensured ongoing promotion and delivery of smoking cessation services and programs, iCanQuit.com.au and Quitline, including the provision of Aboriginal Quitline services and translation services to people from non-English speaking communities.
- Implemented the new skin cancer prevention campaign, Pretty Shady. This digital campaign targeted the sun protection message at tech-savvy teenagers throughout the 2013–14 summer, and motivated thousands of 13 to 24-year-olds to join the Pretty Shady ‘movement’ and change their sun protection behaviour. The campaign is planned to continue in 2014–15.
- Supported a number of community-based projects that aim to break down cultural taboos associated with cancer. For example, the Alive and Out There project is aimed at addressing the cancer myths and misconceptions in the Arab, Greek and Macedonian communities with in-language plays. These plays have had several repeat seasons and the Macedonian play recently returned from a tour of seven cities in Macedonia. Educational videos were also developed about breast and cervical screening for women in Arabic and Mandarin-speaking communities, as well as an English version for women in low socioeconomic communities.
- Developed the Aboriginal Cancer Partnerships Grants Program to support five lead Aboriginal Community Controlled Health Services across NSW to deliver projects that enhance relationships between these organisations and cancer services, build staff capacity and improve the quality of care for Aboriginal people with cancer and their families.
- The Reporting for Better Cancer Outcomes Program has expanded to include more than 40 routinely-reported outcome measures to highlight the State’s cancer health system performance at the local health district and Medicare Local level.
- Finalised merger of the NSW Cancer Registries. This means that we are now capturing both cancer cases and clinical (treatment-based) information in one system, providing greater insight into cancer system performance. This is a critical step in achieving a population-based understanding of variations in treatment that may impact on outcomes experienced by people with cancer.
- The Institute’s eviQ Cancer Treatments Online website now has 40,000+ registered users from more than 148 countries, and receives approximately 800 new registrants each month. It has secured national endorsement from each state and territory (through the Council of Australian Governments) as the preferred provider of evidence-based cancer treatment protocols. The Union for International Cancer Control has also included eviQ on its Cancer Partnerships Portal.
- The eviQ Education Antineoplastic Drug Administration Course is now being used in 235 hospitals and cancer centres across Australia, including 85 in NSW. This year, eviQ Education introduced a paediatric Antineoplastic Drug Administration Course and radiation oncology modules to its suite of online and blended educational programs.
- Funded three new Translational Cancer Research Centres – Hunter Cancer Research Alliance, the Centre for Oncology Education and Research Translation and Sydney Vital. Now seven in total, these centres will continue to bring together researchers and clinicians from local health districts to collaborate on cancer programs.
The Institute will continue to strengthen its collaboration with the NSW Ministry of Health, pillars, local health districts, cancer organisations and the community to identify synergies and add value to each of our endeavours as we work to improve health outcomes across the state.